Free tool
Drug Trial Radar
Last checked: Nov 20, 2026Latest source record: Nov 18, 2026 (registry update on this page)ClinicalTrials.gov last updated: Nov 20, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Matching drug trials
4
Recruiting, any sponsor type, condition "achondroplasia"
By trial status
The same filters, counted in each status. Pick one to switch.
4 trials
Showing 1 to 4, recently updated first.
Tyra Biosciences, IncIndustry
NCT06842355 · 92 participants (planned) · Start Mar 4, 2025 · Primary completion Jan 2030
Drug: TYRA-300 0.125 mg/kg; TYRA-300 0.25 mg/kg and 3 more · For: Achondroplasia
Sites: Torrance, California; Aurora, Colorado; Wilmington, Delaware · 26 sites in all
- Study to Evaluate the Efficacy and Safety of BMN 333 Versus Vosoritide in Children With AchondroplasiaPivotal-lookingRecruiting
BioMarin PharmaceuticalBioMarin (BMRN)
NCT07441876 · 160 participants (planned) · Start Apr 20, 2026 · Primary completion Jun 2029
Drug: BMN 333; Vosoritide Injection [Voxzogo] · For: Achondroplasia
Sites: Oakland, California; Wilmington, Delaware; Chicago, Illinois · 28 sites in all
QED Therapeutics, a BridgeBio companyIndustry
NCT07169279 · 77 participants (planned) · Start Nov 19, 2025 · Primary completion Mar 2030
Drug: Infigratinib is provided as a single dose of minitablets for oral administration; Infigratinib is provided as sprinkle capsules for daily oral administration and 2 more · For: Achondroplasia
Sites: Oakland, California; Baltimore, Maryland; Madison, Wisconsin · 12 sites in all
Ascendis Pharma A/SIndustry
NCT06079398 · 72 participants (planned) · Start Jan 23, 2024 · Primary completion Dec 2027
Drug: Navepegritide; Placebo for Navepegritide · For: Achondroplasia
Sites: Saint Paul, Minnesota; Houston, Texas; Madison, Wisconsin · 18 sites in all
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.